| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,942.0 | 1,869.0 |
| Gross profit | 825.0 | 799.0 |
| Profit before tax | -134.0 | 130.0 |
| Net income | -55.0 | 40.0 |
| EPS (diluted, $ a share) | $-0.22 | $0.16 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +3.9% |
|---|---|
| Gross margin | 42.5% |
| Operating margin | 8.2% |
10-Q filed with the SEC, NYSE: IFF. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
International Flavors & Fragrances Inc: key numbers
- Share price
- $79.43Close, Nov 17
- Market cap
- $19.9B
- Shares outstanding
- 250.39MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Industrial Organic ChemicalsSIC 2860
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from International Flavors & Fragrances Inc
All →International Flavors & Fragrances Stock Plan Amendment
International Flavors & Fragrances approved one-time transaction incentive awards for its executive leadership team tied to the pending sale of its Food Ingredients business. CEO J. Erik Fyrwald received $700,000 in RSUs with three-year cliff vesting, while other named executive officers received cash awards ranging from $350,000 to $700,000, all contingent upon the successful closing of the divestiture.
- Term
- 3 years
International Flavors & Fragrances Financial Results
IFF reported third quarter 2026 financial results with net sales of $1.94 billion, representing a 4% increase over the prior year. The company raised the low end of its full-year 2026 guidance and confirmed it recently completed a $500 million share repurchase program.
- Term
- Q3 2026
“IFF delivered a solid third quarter, with improved sales and profitability across all divisions. Taste and Scent delivered strong top- and bottom-line results, and Health & Biosciences improved modestly as we continue to strengthen the business. We also generated strong cash flow through the first nine months of 2026 and recently completed our $500 million accelerated share repurchase program. The separation of Food Ingredients is progressing well, and we are on track with our timeline to close.”
Erik Fyrwald, CEO of IFF
“Heading into year-end, we are raising the low end of our full-year financial guidance ranges, supported by our year-to-date performance. Volumes remain solid as customers continue to value our strong R&D and innovation. At the same time, we expect fourth-quarter profitability to be softer, particularly in Health & Biosciences, reflecting higher costs as well as reinvestments to strengthen the business. Amid changing macroeconomic conditions, we remain focused on what we can control and are delivering on the financial commitments we set out earlier this year. Our continued execution and these actions give us confidence to deliver results within our full-year financial outlook and our ability to create long-term value for shareholders.”
Erik Fyrwald, CEO of IFF